Canterbury, United Kingdom

John Edward Kemp


Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Canterbury, EN (1976 - 1977)
  • Canterbury, GB (1982 - 1995)

Company Filing History:


Years Active: 1976-1995

Loading Chart...
9 patents (USPTO):Explore Patents

Title: John Edward Kemp: Innovator in Pharmaceutical Chemistry

Introduction

John Edward Kemp is a notable inventor based in Canterbury, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are several groundbreaking inventions. These include "Certain 1-azabicyclo[2.2.1]heptanes useful as muscarinic receptor," "4-Substituted-1-(4-alkylsulphonamidophenyl)piperazines as antiarrhythmic," and "Antiarrhythmic agents of the formula: ##STR1## and their pharmaceutically acceptable salts, wherein R and R.sup.1, which are the same or different, are C.sub.1 -C.sub.4 alkyl, C.sub.3 -C.sub.7 cycloalkyl, --CH.sub.2 CH.sub.3, --CH.sub.2 Cl, --CF.sub.3 or --NH.sub.2."

Career Highlights

John Edward Kemp has built a successful career at Pfizer Corporation, where he continues to innovate and contribute to the development of new pharmaceutical agents. His expertise in medicinal chemistry has positioned him as a key player in the industry.

Collaborations

Throughout his career, Kemp has collaborated with esteemed colleagues, including Peter E Cross and John C Danilewicz. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

John Edward Kemp's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field and advance therapeutic options for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…